Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-124 (miR-124) is a small non-coding RNA molecule that regulates gene expression at the post-transcriptional level. It is highly expressed in the central nervous system and immune cells, playing critical roles in neuronal differentiation, immune modulation, and tumor suppression. It functions by binding to target mRNAs, leading to their degradation or translational repression. miR-124 has potential as a therapeutic target and biomarker for various diseases, particularly cancer and neurological disorders.
Post-transcriptional regulation via RISC binding to mRNA, leading to mRNA degradation or translational repression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-124 (miR-124).